miglustat has been researched along with celgosivir in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Bowlin, TL; Kang, MS; Liu, PS; Sunkara, PS; Taylor, DL; Tyms, AS | 1 |
Kazungu, Y; Marcello, A; Martinez-Orellana, P; Milan Bonotto, R; Nascimento Alves, L; Poggianella, M; Polez, S; Rajasekharan, S; Skoko, N | 1 |
2 other study(ies) available for miglustat and celgosivir
Article | Year |
---|---|
6-0-butanoylcastanospermine (MDL 28,574) inhibits glycoprotein processing and the growth of HIVs.
Topics: 1-Deoxynojirimycin; alpha-Glucosidases; Animals; Cell Line; Cell Line, Transformed; Dose-Response Relationship, Drug; Gene Products, env; Glucosamine; Glycoside Hydrolase Inhibitors; HIV Envelope Protein gp120; HIV Envelope Protein gp160; HIV-1; Humans; Indolizines; Mice; Moloney murine leukemia virus; Protein Precursors; Viral Plaque Assay; Zalcitabine | 1991 |
Inhibitors of Protein Glycosylation Are Active against the Coronavirus Severe Acute Respiratory Syndrome Coronavirus SARS-CoV-2.
Topics: 1-Deoxynojirimycin; A549 Cells; Animals; Antiviral Agents; Chlorocebus aethiops; COVID-19 Drug Treatment; Drug Repositioning; Glycoside Hydrolase Inhibitors; Glycosylation; HEK293 Cells; Humans; Indolizines; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells; Virus Release | 2021 |